Squarepoint
CPXX

Squarepoint’s CELATOR PHARMACEUTICALS INC. COMMON STOCK CPXX Stock Holding History

Squarepoint’s Portfolio CPXX Stock Details CPXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-12,600
Closed -$380K – 1476
2016
Q2 		$380K Buy
+12,600
New +$256K 0.02% 644

Squarepoint's CPXX Position: Q3 2016 in Review

Squarepoint sold out of CELATOR PHARMACEUTICALS INC. COMMON STOCK (CPXX) in Q3 2016, closing a stake of 12,600 shares — an estimated $380K sold.

Squarepoint first reported a position in CPXX in Q2 2016 and held it in 1 quarter. The position peaked at $380K in Q2 2016. 0 funds tracked by Wall St. Rank hold CPXX as of Q3 2016.

  • Squarepoint reported no remaining CELATOR PHARMACEUTICALS INC. COMMON STOCK position as of Q3 2016 after selling out during the quarter.
  • Squarepoint sold 12,600 CELATOR PHARMACEUTICALS INC. COMMON STOCK shares in Q3 2016, an estimated $380K.
  • Squarepoint first reported a position in CELATOR PHARMACEUTICALS INC. COMMON STOCK in Q2 2016 and held it in 1 quarter.
  • Squarepoint's CELATOR PHARMACEUTICALS INC. COMMON STOCK position peaked at $380K in Q2 2016.
  • 0 funds tracked by Wall St. Rank held CELATOR PHARMACEUTICALS INC. COMMON STOCK as of Q3 2016.

Based on Squarepoint's 13F filing for Q3 2016, filed 15 Nov 2016.